DADC
NXTM

D.A. Davidson & Co’s NxStage Medical Inc. NXTM Stock Holding History

D.A. Davidson & Co’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-1,000
Closed -$25K – 2260
2017
Q2 		$25K Hold
1,000
– – ﹤0.01% 1765
2017
Q1 		$26K Hold
1,000
– – ﹤0.01% 1758
2016
Q4 		$26K Hold
1,000
– – ﹤0.01% 1850
2016
Q3 		$24K Sell
1,000
-400
-29% -$9.33K ﹤0.01% 1804
2016
Q2 		$30K Buy
1,400
+1,000
+250% +$17.8K ﹤0.01% 1615
2016
Q1 		$5K Hold
400
– – ﹤0.01% 2059
2015
Q4 		$8K Buy
+400
New +$7.45K ﹤0.01% 1952

Other funds holding NXTM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PCM
Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

D.A. Davidson & Co's NXTM Position: Q3 2017 in Review

D.A. Davidson & Co sold out of NxStage Medical Inc. (NXTM) in Q3 2017, closing a stake of 1,000 shares — an estimated $25K sold.

D.A. Davidson & Co first reported a position in NXTM in Q4 2015 and held it in 7 quarters. The position peaked at $30K in Q2 2016. 168 funds tracked by Wall St. Rank hold NXTM as of Q3 2017.

  • D.A. Davidson & Co reported no remaining NxStage Medical Inc. position as of Q3 2017 after selling out during the quarter.
  • D.A. Davidson & Co sold 1,000 NxStage Medical Inc. shares in Q3 2017, an estimated $25K.
  • D.A. Davidson & Co first reported a position in NxStage Medical Inc. in Q4 2015 and held it in 7 quarters.
  • D.A. Davidson & Co's NxStage Medical Inc. position peaked at $30K in Q2 2016.
  • 168 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q3 2017.

Based on D.A. Davidson & Co's 13F filing for Q3 2017, filed 8 Nov 2017.